Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Unusual Lacrimal Gland Tumor Epidemiology Explained

Unusual Lacrimal Gland Tumor Epidemiology Explained Letters egorical covariate instead of as the time scale in the Cox analy- COMMENT & RESPONSE sis, which was necessary because NHANES truncates age at 80 Unusual Lacrimal Gland Tumor years for confidentiality purposes. This parameterization of age may result in residual confounding owing to the inability to Epidemiology Explained To the Editor Mallen-St Clair and colleagues provided a wealth precisely adjust for differences in age. of data in their recent article on the epidemiology and treat- Future studies are required to explore the basis of the ment of lacrimal gland tumors. The authors have unfortu- association of HI with mortality and to determine whether nately overlooked a flaw in the methods that significantly lim- therapies to rehabilitate hearing can reduce mortality. its the utility of the data. In the Surveillance, Epidemiology, and End Results Program (SEER) database, tumors of both the Kevin J. Contrera, MPH lacrimal gland and lacrimal sac are coded C69.5. Josh Betz, MS This explains the vastly different distribution of malig- Dane J. Genther, MD nant lacrimal gland tumors seen in clinical practice and prior Frank R. Lin, MD, PhD series. The authors comment on their surprise to find that squa- mous cell carcinoma represented http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Unusual Lacrimal Gland Tumor Epidemiology Explained

Loading next page...
 
/lp/american-medical-association/unusual-lacrimal-gland-tumor-epidemiology-explained-RiZzlBT9eY
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2015.2045
Publisher site
See Article on Publisher Site

Abstract

Letters egorical covariate instead of as the time scale in the Cox analy- COMMENT & RESPONSE sis, which was necessary because NHANES truncates age at 80 Unusual Lacrimal Gland Tumor years for confidentiality purposes. This parameterization of age may result in residual confounding owing to the inability to Epidemiology Explained To the Editor Mallen-St Clair and colleagues provided a wealth precisely adjust for differences in age. of data in their recent article on the epidemiology and treat- Future studies are required to explore the basis of the ment of lacrimal gland tumors. The authors have unfortu- association of HI with mortality and to determine whether nately overlooked a flaw in the methods that significantly lim- therapies to rehabilitate hearing can reduce mortality. its the utility of the data. In the Surveillance, Epidemiology, and End Results Program (SEER) database, tumors of both the Kevin J. Contrera, MPH lacrimal gland and lacrimal sac are coded C69.5. Josh Betz, MS This explains the vastly different distribution of malig- Dane J. Genther, MD nant lacrimal gland tumors seen in clinical practice and prior Frank R. Lin, MD, PhD series. The authors comment on their surprise to find that squa- mous cell carcinoma represented

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Oct 1, 2015

References